Letter: Acneiform lesions in combined rifampicin treatment in Africans.
D000152:Acne Vulgaris / Q000139:chemically induced*; D000328:Adult; D003875:Drug Eruptions / Q000209:etiology*; D005260:Female; D006801:Humans; D007538:Isoniazid / Q000627:therapeutic use; D008297:Male; D012293:Rifampin / Q000009:adverse effects* / Q000627:therapeutic use; D013828:Thioacetazone / Q000627:therapeutic use; D014401:Tuberculosis, Urogenital / Q000188:drug therapy; D015024:Zambia
D013828:Thioacetazone; D007538:Isoniazid; D012293:Rifampin